← Back to patent-cliff list
CAS 1357476-68-6
N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)acetamide
Codes: ALPE-008
Application context (from source-drug indications)
Growth disorderAlpelisibGenetic diseaseAlpelisibPIK3CA-related overgrowth spectrumAlpelisibBreast cancerAlpelisib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alpelisib | Tier C — Watch / trade | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,3,3-trifluoro-2,2-dimethylpropanoic acid→3,3,3-trifluoro-2,2-dimethylpropanoyl chloride→ethyl 3-oxo-3-((3-(trifluoromethyl)phenyl)amino)propanoate→2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4H-pyran-4-one→2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4(1H)-one→4-bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine→N-(4-methylthiazol-2-yl)acetamide→N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)acetamide→4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-amine→N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)-1H-imidazole-1-carboxamide→(S)-pyrrolidine-2-carboxamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.